Indivior PLC (INDV)

Currency in GBP
12.38
+0.19(+1.56%)
Closed·
Showing Indivior historical data. For real-time data please try another search
Fair Value
Day's Range
12.3012.64
52 wk Range
6.911,179.00
Key Statistics
Bid/Ask
1,231.00 / 1,335.00
Prev. Close
1,219
Open
12.48
Day's Range
12.3-12.64
52 wk Range
6.91-1,179
Volume
8.73M
Average Volume (3m)
439.22K
1-Year Change
-98.75%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INDV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Indivior PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Indivior PLC Company Profile

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Employees
1041

Compare INDV to Peers and Sector

Metrics to compare
INDV
Peers
Sector
Relationship
P/E Ratio
−34.5x14.5x−0.5x
PEG Ratio
0.000.130.00
Price/Book
−7.5x2.6x2.6x
Price / LTM Sales
1.8x3.4x3.2x
Upside (Analyst Target)
-27.8%41.2%
Fair Value Upside
Unlock13.0%6.2%Unlock

Earnings

Latest Release
May 01, 2025
EPS / Forecast
0.38 / 0.2525
Revenue / Forecast
266.00M / 248.15M
EPS Revisions
Last 90 days

INDV Income Statement

People Also Watch

268.39
AVAV
-0.83%
109.38
CRDO
+1.32%
189.19
HWM
+0.54%
118.34
ALAB
-4.60%
11.630
CRMD
-2.92%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.